Supernus Pharmaceuticals (SUPN)
(Delayed Data from NSDQ)
$27.15 USD
-0.39 (-1.42%)
Updated Jun 6, 2024 04:00 PM ET
After-Market: $27.13 -0.02 (-0.07%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth A Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $0.37 | 0.00% |
Earnings Summary
For their last quarter, Supernus Pharmaceuticals (SUPN) reported earnings of $0.00 per share, missing the Zacks Consensus Estimate of $0.39 per share. This reflects a negative earnings surprise of 100.00%. Look out for SUPN's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of $0.37 per share, reflecting a year-over-year increase of 1950%.
Earnings History
Price & Consensus
Zacks News for SUPN
Compared to Estimates, Supernus (SUPN) Q1 Earnings: A Look at Key Metrics
SUPN: What are Zacks experts saying now?
Zacks Private Portfolio Services